drugset / Trial / NCT06115408

Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma

NCT06115408

Phase 2/3 Completed 40 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindHealth-services research

Summary

This 2 arm randomized clinical trial will assess the impact of Dienogest and N-Acetyl Cysteine on volume reduction of uterine leiomyoma

Timeline

Start
2023-09-01
Primary completion
2024-08-31
Completion
2024-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg Oral
Subject N-acetylcysteine Small molecule 600 mg Oral